Caregiving & Parkinson's

November is recognized as National Family Caregivers Month, which is an important part of the Parkinson's Foundation efforts to honor the contributions of the 65 million people in the U.S. who care for a loved one who is aging or living with a chronic condition like Parkinson's disease (PD). We have a special interview with John L. Lehr, President and CEO of the non-profit Parkinson’s Foundation, and Gil Kim, who is the primary care partner for his wife, Gina, who was diagnosed with PD in 2011.<br /><b></b><br />John<b> </b>L. Lehr leads the Parkinson's Foundation as president &amp; chief executive officer. He has nearly three decades of nonprofit fundraising and management experience, with a strong focus in the voluntary healthcare and medical research sectors. John played a key role in merging two legacy Parkinson’s organizations into the Parkinson’s Foundation in 2017. Since joining the Foundation, fundraising revenue has grown each year by double digits, allowing the Foundation to greatly expand its mission programs. John led the efforts to open 17 regional chapters to better serve local Parkinson’s communities. These developments and other initiatives have allowed the Foundation to earn a 4-star rating from Charity Navigator, a Platinum Seal of Transparency from GuideStar, and to be named to the 2020 list of Best Places to Work by The Non-Profit Times. During his tenure at the Foundation, John has overseen several major initiatives including:<ul><li>Expanding the Foundation’s Center of Excellence Network to 47 Centers globally;</li><li>Launching PDGeneration: Mapping the Future of Parkinson’s Disease, a groundbreaking study to gather genetic data for research and drug development on thousands of people with PD by offering free genetic testing and counseling;</li><li>Co-hosting the Parkinson’s Policy Forum to align the Parkinson’s community around key issues, and to petition state and federal lawmakers to take action on pressing patient needs and policy changes.</li><li>And, launching the Newly Diagnosed Ini